Metabolon Signs Collaboration with Army Medical Research Institute
News Nov 12, 2007
Metabolon, Inc. has announced the signing of a contract supporting the US Army Medical Research Institute of Infectious Diseases (USAMRIID).
The collaboration uses Metabolon’s proprietary metabolomics platform to study the biochemical profiles of humans given the AVA anthrax vaccine. The AVA vaccine is the only FDA-licensed anthrax vaccine for humans.
“This collaboration represents the first large-scale metabolomics study of human subjects given a vaccine,” said Mike Milburn, Metabolon’s Chief Scientific Officer. “This type of comprehensive biochemical profiling will help USAMRIID better understand the vaccine’s safety, efficacy, and mechanism of action.”
Peering Inside ProteinsNews
The proteins in our bodies are sophisticated structures that perform specific jobs to keep us functioning and healthy. Understanding how a protein is wired could help researchers develop ways to control its activity. A new technique lets researchers look into the atomic structures of proteins to see that wiring.READ MORE
This ATM Dispenses AntioxidantsNews
Antioxidants are molecules that counteract the damage to our bodies from harmful products of normal cells called reactive oxygen species (ROS). Now, research has found that a protein called ATM can sense the presence of ROS and responds by sounding the alarm to trigger the production of antioxidants.READ MORE